Department for Sustainability

Found 4 results

Filters: Author is Radaelli, A. [Clear All Filters]

2016

Prime–boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X, Illiano, E., Bissa M., Paolini F., Zanotto C., C. Morghen De Giuli, Franconi Rosella, Radaelli A., and Venuti A. , Virus Research, Volume 225, p.82-90, (2016)

Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: Implications for HPV-tumor diagnosis and therapy, Illiano, E., Demurtas Olivia Costantina, Massa Silvia, Bonito P., Consalvi V., Chiaraluce R., Zanotto C., C. Morghen Giuli, Radaelli A., Venuti A., et al. , Journal of Translational Medicine, Volume 14, Number 1, p.1–14, (2016)

2015

A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers, Bissa, M., Illiano E., Pacchioni S., Paolini F., Zanotto C., C. Morghen De Giuli, Massa Silvia, Franconi Rosella, Radaelli A., and Venuti A. , Journal of Translational Medicine, Volume 13, Number 1, (2015)

2012

A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers, Radaelli, A., C. Morghen De Giuli, Zanotto C., Pacchioni S., Bissa M., Franconi Rosella, Massa Silvia, Paolini F., Muller A., and Venuti A. , Virus Research, Volume 170, Number 1-2, p.44-52, (2012)